Letícia Streck
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Letícia Streck has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Arnóbio Antônio da Silva-Júnior
Laboratory of Technology and Pharmaceutical Biotechnology (Tecbiofar), College of Pharmacy, Federal University of Rio Grande do Norte, Avenue General Gustavo Cordeiro de Farias, S/N, Petrópolis, Natal, 59012-570, Brazil
2 shared publications - Matheus de Freitas Fernandes-Pedrosa
Laboratory of Technology and Pharmaceutical Biotechnology (Tecbiofar), College of Pharmacy, Federal University of Rio Grande do Norte, Avenue General Gustavo Cordeiro de Farias, S/N, Petrópolis, Natal, 59012-570, Brazil
2 shared publications - Anselmo Gomes de Oliveira
São Paulo State University (UNESP), Graduate Program in Pharmaceutical Sciences, School of Pharmaceutical Sciences, Rodovia Araraquara-Jaú, km 01, 14, Araraquara, SP 800-903, Brazil
1 shared publication - Ariana Zoppi
Unidad de Investigación y Desarrollo en Tecnología Farmacéutica, UNITEFA-CONICET, Facultad de Ciencias Químicas, Departamento de Ciencias Farmacéuticas, Universidad Nacional de Córdoba, Córdoba, Argentina
1 shared publication Arnóbio A. da Silva-Júnior
Departamento de Farmácia, Universidade Federal do Rio Grande do Norte, 59012570, Natal, RN, Brazil
1 shared publication- Arthur Sérgio Avelino de Medeiros
Laboratory of Pharmaceutical Technology and Biotechnology, Department of Pharmacy, Federal University of Rio Grande do Norte-UFRN, Natal 59010-180, Brazil
1 shared publication
Latest Publications
- 7 July 2020
- Published by Pleiades Publishing Ltd in Journal of Analytical Chemistry
- Vol. 75 (7) , 922-929
High Performance Liquid Chromatography–Diode Array Detector Method for Benznidazole Quantitation in Lipid Based and Self Assembling Cyclodextrins Drug Delivery Systems
The challenge of the present work concerned in benznidazole assay in two drug delivery systems (DDS) which are different in the solubility character and sample complexity using HPLC−diode array detector (DAD) method. The lipid based DDS were mainly composed of medium-chain triglycerides and a mixture of surfactants, while the multicomponent inclusion complex systems involved cosolvents and different cyclodextrins. The method was validated according to the International Conference on Harmonization guidelines. The linearity of the standard curves was greater than 0.999 (r2) with the limits of detection of 0.05 µg/mL and quantification of 0.18 µg/mL. The method was specific, precise (RSD < 1.99%) and robust. The different drug interactions with systems did not alter the recovery which ranged from 93 to 106% for the distinct DDS. Statistical data analysis of different DDS demonstrated that selected parameters for HPLC−DAD method offered equivalent results and could be applied for stability studies and quality control of these drug delivery systems.
- 7 July 2020
- Published by Pleiades Publishing Ltd in Journal of Analytical Chemistry
- Vol. 75 (7) , 922-929
High Performance Liquid Chromatography–Diode Array Detector Method for Benznidazole Quantitation in Lipid Based and Self Assembling Cyclodextrins Drug Delivery Systems
The challenge of the present work concerned in benznidazole assay in two drug delivery systems (DDS) which are different in the solubility character and sample complexity using HPLC−diode array detector (DAD) method. The lipid based DDS were mainly composed of medium-chain triglycerides and a mixture of surfactants, while the multicomponent inclusion complex systems involved cosolvents and different cyclodextrins. The method was validated according to the International Conference on Harmonization guidelines. The linearity of the standard curves was greater than 0.999 (r2) with the limits of detection of 0.05 µg/mL and quantification of 0.18 µg/mL. The method was specific, precise (RSD < 1.99%) and robust. The different drug interactions with systems did not alter the recovery which ranged from 93 to 106% for the distinct DDS. Statistical data analysis of different DDS demonstrated that selected parameters for HPLC−DAD method offered equivalent results and could be applied for stability studies and quality control of these drug delivery systems.
- Open Access
- 30 June 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (7) , 981
Phase Transitions of Isotropic to Anisotropic Biocompatible Lipid-Based Drug Delivery Systems Overcoming Insoluble Benznidazole Loading
Previous studies reported low benznidazole (BNZ) loading in conventional emulsions due to the weak interaction of the drug with the most common oils used to produce foods or pharmaceuticals. In this study, we focused on how the type of surfactant, surfactant-to-oil ratio w/w (SOR) and oil-to-water ratio w/w (OWR) change the phase behavior of different lipid-based drug delivery systems (LBDDS) produced by emulsion phase inversion. The surfactant mixture composed of soy phosphatidylcholine and sodium oleate (1:7, w/w, hydrophilic lipophilic balance = 16) stabilized medium chain triglyceride in water. Ten formulations with the clear aspect or less turbid dispersions (five with the SOR ranging from 0.5 to 2.5 and five with the OWR from 0.06 to 0.4) were selected from the phase behavior diagram to assess structural features and drug-loading capacity. The rise in the SOR induced the formation of distinct lipid-based drug delivery systems (nanoemulsions and liquid crystal lamellar type) that were identified using rheological measurements and cross-polarized light microscopy images. Clear dispersions of small and narrow droplet-sized liquid-like nanoemulsions, Newtonian flow-type, were produced at SOR from 0.5 to 1.5 and OWR from 0.12 to 0.4, while clear liquid or gel-like liquid crystals were produced at SOR from 1.5 to 2.5. The BNZ loading was improved according to the composition and type of LBDDS produced, suggesting possible drug location among surfactant layers. The cell viability assays proved the biocompatibility for all of the prepared nanoemulsions at SOR less than 1.5 and liquid crystals at SOR less than 2.5, demonstrating their promising features for the oral or parenteral colloidal delivery systems containing benznidazole for Chagas disease treatment.
- 30 June 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (7) , 981
Open AccessPhase Transitions of Isotropic to Anisotropic Biocompatible Lipid-Based Drug Delivery Systems Overcoming Insoluble Benznidazole Loading
Previous studies reported low benznidazole (BNZ) loading in conventional emulsions due to the weak interaction of the drug with the most common oils used to produce foods or pharmaceuticals. In this study, we focused on how the type of surfactant, surfactant-to-oil ratio w/w (SOR) and oil-to-water ratio w/w (OWR) change the phase behavior of different lipid-based drug delivery systems (LBDDS) produced by emulsion phase inversion. The surfactant mixture composed of soy phosphatidylcholine and sodium oleate (1:7, w/w, hydrophilic lipophilic balance = 16) stabilized medium chain triglyceride in water. Ten formulations with the clear aspect or less turbid dispersions (five with the SOR ranging from 0.5 to 2.5 and five with the OWR from 0.06 to 0.4) were selected from the phase behavior diagram to assess structural features and drug-loading capacity. The rise in the SOR induced the formation of distinct lipid-based drug delivery systems (nanoemulsions and liquid crystal lamellar type) that were identified using rheological measurements and cross-polarized light microscopy images. Clear dispersions of small and narrow droplet-sized liquid-like nanoemulsions, Newtonian flow-type, were produced at SOR from 0.5 to 1.5 and OWR from 0.12 to 0.4, while clear liquid or gel-like liquid crystals were produced at SOR from 1.5 to 2.5. The BNZ loading was improved according to the composition and type of LBDDS produced, suggesting possible drug location among surfactant layers. The cell viability assays proved the biocompatibility for all of the prepared nanoemulsions at SOR less than 1.5 and liquid crystals at SOR less than 2.5, demonstrating their promising features for the oral or parenteral colloidal delivery systems containing benznidazole for Chagas disease treatment.
- Open Access
- 25 September 2014
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 15 (9) , 17077-17099
Triethanolamine Stabilization of Methotrexate-β-Cyclodextrin Interactions in Ternary Complexes
The interaction of methotrexate (MTX) with beta-cyclodextrin (β-CD) in the presence of triethanolamine (TEA) was investigated with the aim to elucidate the mechanism whereby self-assembly cyclodextrin systems work in association with this third component. Solubility diagram studies showed synergic increment of the MTX solubility to be about thirty-fold. Experiments using 2D ROESY and molecular modeling studies revealed the inclusion of aromatic ring III of the drug into β-CD cavity, in which TEA contributes by intensifying MTX interaction with β-CD and stabilizes MTX:β-CD:TEA ternary complex by electrostatic interaction. The maintenance of these interactions in solid phase was also studied in ternary MTX:β-CD:TEA and comparisons were made with freeze dried binary MTX:β-CD and physical mixtures. FTIR studies evidenced that MTX–β-CD interaction remained in solid ternary complexes, which was also supported by thermal (differential scanning calorimetry (DSC), thermogravimetric analysis (TG)/first derivative of TG analysis (DTG) and C,N,H elementary analysis) and structural (X-ray diffraction analysis, (XRD)) studies, mainly regarding the increment of drug stability. The efficient in vitro drug dissolution studies successfully demonstrated the contribution of ternary complexes, which highlights the importance of this possible new raw material for further applications in drug delivery systems.
- 25 September 2014
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 15 (9) , 17077-17099
Open AccessTriethanolamine Stabilization of Methotrexate-β-Cyclodextrin Interactions in Ternary Complexes
The interaction of methotrexate (MTX) with beta-cyclodextrin (β-CD) in the presence of triethanolamine (TEA) was investigated with the aim to elucidate the mechanism whereby self-assembly cyclodextrin systems work in association with this third component. Solubility diagram studies showed synergic increment of the MTX solubility to be about thirty-fold. Experiments using 2D ROESY and molecular modeling studies revealed the inclusion of aromatic ring III of the drug into β-CD cavity, in which TEA contributes by intensifying MTX interaction with β-CD and stabilizes MTX:β-CD:TEA ternary complex by electrostatic interaction. The maintenance of these interactions in solid phase was also studied in ternary MTX:β-CD:TEA and comparisons were made with freeze dried binary MTX:β-CD and physical mixtures. FTIR studies evidenced that MTX–β-CD interaction remained in solid ternary complexes, which was also supported by thermal (differential scanning calorimetry (DSC), thermogravimetric analysis (TG)/first derivative of TG analysis (DTG) and C,N,H elementary analysis) and structural (X-ray diffraction analysis, (XRD)) studies, mainly regarding the increment of drug stability. The efficient in vitro drug dissolution studies successfully demonstrated the contribution of ternary complexes, which highlights the importance of this possible new raw material for further applications in drug delivery systems.